SYSTEM AND METHOD OF USING TEMPORAL MEASUREMENTS OF LOCALIZED RADIATION TO ESTIMATE THE MAGNITUDE, LOCATION, AND VOLUME OF RADIOACTIVE MATERIAL IN THE BODY
20210015434 ยท 2021-01-21
Inventors
Cpc classification
G01T1/161
PHYSICS
A61B6/4258
HUMAN NECESSITIES
A61B6/504
HUMAN NECESSITIES
A61B6/486
HUMAN NECESSITIES
G01S17/48
PHYSICS
G01S17/42
PHYSICS
A61B6/4057
HUMAN NECESSITIES
International classification
Abstract
A system and method for the measurement of radiation emitted from the body, for example, is presented. In one example, radiation sensors (e.g., gamma radiation sensors) may be used to measure activity proximate an injection site as a function of time. In some embodiments, one or more rangefinders may be employed to determine a size and/or position of a subject relative to the radiation sensors to better account for varying material densities within the system in estimating, for example, the amount of radioactive material in the tissue proximate the injection site. With an estimated function of radioactive material proximate the injection site as a function of time known, an estimated arterial input function may be determined, allowing for calculation of a correction factor that may be applied by a clinician during nuclear medical imaging. The magnitude, location, and volume of the radioactive source in the body may also be estimated.
Claims
1. A method for the ex vivo real-time determination over a period of time of one or more of the magnitude, location, and volume of radioactive material in the body by measuring radiation that decays in vivo emitted by a subject, the method comprising: (i) applying one or more ex vivo radiation measurement sensors proximate an area of interest on a patient; (ii) applying one or more rangefinders proximate an area of interest on a patient for determining a position of the subject relative to the one or more radiation measurement sensors; (iii) detecting radiation over a desired period of time and producing signal data associated with the desired period of time; (iii) amplifying the signal data using a signal amplifier in operable communication with the radiation measurement sensor, wherein the radiation measurement sensor has at least one sensor output for such amplified signal data, and outputting the amplified signal data; (iv) processing the amplified signal data using a computer processor in operative communication with a non-transient memory and the measurement sensor output by performing the steps of: (a) receiving the amplified signal data associated with the desired period of time; (b) comparing the amplified signal data to a set of expected signal data for radioactive sources of various magnitudes, locations, and volumes within a subject at the position determined by the one or more rangefinders; (c) determining one or more of a magnitude, location, and volume of the radioactive source in the body over the desired period of time by fitting the amplified signal data to the most likely set of expected signal data.
2. The method of claim 1, wherein a Maximum Likelihood Expectation Maximization method is used to fit the most likely magnitude, location, and volume of the radioactive source in the body.
3. The method of claim 1, further comprising the step of determining a dose of radioactivity to an area of tissue proximate the location of the radioactive source.
4. The method of claim 1, further comprising the step of using the determined one or more magnitude, location, and volume of radioactive source in the body to make one or more of a clinical decision or diagnosis.
5. The method of claim 1, wherein an array comprising two or more of the ex vivo radiation measurement sensors and two or more rangefinders are utilized.
6. The method of claim 5, wherein the array of two or more radiation measurement sensors and two or more rangefinders are disposed in a substantially symmetric geometry about the radioactive source in the body.
7. The method of claim 5, wherein the two or more sensors are disposed proximate one or more desired measurement location, and further wherein each desired measurement location comprises at least a first sensor disposed relatively closer to the radioactive source than a second sensor.
8. The method of claim 1, wherein one or more of a magnitude, location, or volume is determined for two or more radiation sources in the body.
9. The method of claim 8, further comprising the step of comparing the one or more determined magnitude, location, or volume of the two or more radioactive sources, and making a clinical decision or diagnosis based on the comparison.
10. The method of claim 9, wherein the clinical decision or diagnosis is also based on one or more prior determinations or comparisons of the subject patient.
11. The method of claim 9, wherein the clinical decision or diagnosis is further based on a comparison to a table comprising data from a population of other patients.
12. The method of claim 1, wherein the one or more rangefinders comprises an ultrasound transducer and detector.
13. The method of claim 1, wherein the one or more rangefinders comprises an optical detector.
14. The method of claim 1, wherein the one or more rangefinders comprises a camera and laser system for determining the position of the subject.
15. The method of claim 1, further comprising the step of utilizing the position of the subject to estimate a position of bone within the patient.
16. A system for the ex vivo real-time detection over a period of time of radiation emitted by a subject from the administration of a radioactive analyte that decays in vivo, the system comprising: two or more ex vivo radiation measurement sensors to detect radiation over a desired period of time and to produce signal data associated with the desired period of time, the ex vivo measurement sensors adapted to sensing radiation proximate to a point of administration on the subject of the radioactive analyte and disposed within a deformable cuff comprising two or more detector plates, wherein the two or more detector plates are joined by a pivot point between each pair of detector plates having a sensor for measuring a relative angle between the pair of detector plates in real time such that the relative positions of the two or more sensors disposed within the two or more detector plates are known in real time; a signal amplifier in operable communication with the two or more radiation measurement sensors, the signal amplifier adapted to amplify the signal data, the measurement sensors having at least one sensor output for such amplified signal data; at least one computer processor and a non-transient memory, the computer processor in operable communication with the non-transient memory and the measurement sensor output port; wherein the non-transient memory includes computer program code executable by the at least one computer processor, the computer program code configured for performing the steps of receiving the amplified signal data with the desired period of time, accessing a measured amount of radioactive material proximate the point of administration at a time t, and using the amplified signal data, estimating a function of radioactive material proximate the point of injection as a function of time from a time of injection to time t.
17. The system of claim 16, wherein the measured value of radioactive material proximate the point of administration at time t is measured using the two or more ex vivo radiation measurement sensors disposed on the two or more corresponding detector plates, wherein a distance from the array to a radiometric center of the radioactive material being measured can be determined, and further wherein a volume of the radioactive material being measured can be determined.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
DETAILED DESCRIPTION
[0056] The present disclosure teaches, among other things, systems and methods for using measurements of localized radiation to estimate the magnitude, location, and/or volume of radioactive source materials in the body. In some embodiments, such measurements may be repeated at various points in time to determine temporal changes in magnitude, location, and/or volume of radioactive materials in the body. In some embodiments, such information may be used to correct for non-bolus injections of radiopharmaceuticals. Such systems and methods may allow physicians to better measure, for example, cancer treatment effectiveness. In other embodiments, the systems, devices and methods may be used to validate organ dosimetry, or measure uptake of radiopharmaceuticals in tumors, organs or other areas of interest directly.
[0057] According to a first set of embodiments, and as introduced above, the SUV of a tumorfor example, the ratio of the amount of radio-labeled tracer in an area of interest compared to the level in the rest of the bodymay be calculated using, among other things, molecular imaging data. In general, SUV may be approximated as the integral of concentration of radiotracer in the bloodstream, multiplied by a constant K, plus a variability of distribution volume factor (V.sub.d). In the exemplary equation below, C.sub.T(t) represents the concentration of radiotracer in the tumor, C.sub.B(t) represents the concentration of radiotracer in the blood, K is a constant and V.sub.d is a dimensionless volume of distribution equivalent to a volume of blood that contains the same activity as 1 mL of tissue.
C.sub.T(t)=K.sub.0.sup.TC.sub.B(t)dt+V.sub.d
[0058] When the injection of radiotracer into the patient goes according to plan (i.e., there is no infiltration or extravasation during the injection and the entire dose of radiotracer goes promptly into the patient's bloodstream), the concentration of radiotracer in the blood can be assumed as the arterial input function. The arterial input function or AIF may be referred to as the impulse response for a typical bolus injection, and such impulse responses have been well-studied and measured. When the concentration of radiotracer in the blood cannot be assumed to be a typical bolus injection of known dosage, but instead varies over time as an infiltrated portion of a dose relatively slowly finds its way to the bloodstream, the measured concentration of radiotracer in the tumor becomes a function of both the radiotracer in the bloodstream from the initial (partial) bolus injection, and the later added radiotracer from the infiltration portion. Further, because the magnitude (i.e. the activity) of the infiltration depends on the nature of the infiltration itself (i.e. varies from infiltration to infiltration based on, for example, size of the infiltration, location of the infiltration, local tissue vascularization, etc.), the effective dose into the bloodstream from the bolus portion may be reduced by an unknown amount. The SUV of an area of interest (e.g., a tumor) is therefore altered by an amount proportional to the ratio of the bolus injection integral from a typical injection and the non-bolus injection integral, and may be expressed in some embodiments as follows (where SUV.sub.b is the SUV in the case of a typical bolus injection and SUV.sub.i is the SUV in the case of an infiltrated injection):
[0059] In general, the kinetics of radiotracer uptake can be considered a time-invariant linear system. In this exemplary case, a bolus injection could be the impulse and the normal AIF curve (i.e. concentration of radiotracer in the blood as a function of time) could then be the impulse response. The AIF for a typical bolus injection has been well-studied and measured, such that results and applicable measurements are readily available in the literature. Referring now to
[0060] In the case of an extravasated or infiltrated injection, however, the AIF may be modeled as a convolution of the normal impulse response with the altered input signal that may comprise a decreased initial impulse (the bolus) followed by prolonged decaying exponential reabsorption. The reduced bolus portion may represent the amount of radiotracer that enters circulation immediately. The extended infusion portion may result from sequestered or infiltrated radiotracer being reabsorbed into circulation through, for example, the venous or lymphatic systems. Referring now to
[0061] In cases of infiltration/extravasation, the injection is not a bolus, and thus the input to the linear system is not an impulse. If the true input to the linear system from an extravasated or infiltrated injection is known or can be determined, it may be possible to then calculate how the altered injection shape may impact the scan metrics such as, for example, SUV (e.g. from a PET scan). For example, it is possible to take the altered linear system input following an infiltrated or extravasated injection and convolve it with the known impulse response from a typical bolus injection, thereby yielding the anticipated blood concentration over time for the infiltrated (i.e. extravasation) injection. That convolution of functions can yield a function for concentration of radiotracer in the blood as a function of time (i.e. the Arterial Input Function or AIF) for any case of infiltration or extravasation. Referring now to
[0062] To perform the methods outlined above, a user may need to know the amplitude (i.e. the activity) of the infiltration as well as the rate of reabsorption of the infiltrate (so as to produce the function of radiotracer entering circulation over time). One method of determining the amplitude of radioactivity in a particular region (e.g., the infiltration site) is to use nuclear medicine imaging data taken during an imaging session, which may yield an amplitude in a region at a time=t. This alone, however, cannot enable one to extrapolate the infiltrated amount at the time of injection (t=0), or the rate at which the radiotracer may have been reabsorbed into the bloodstream.
[0063] In some embodiments, localized radiation detectors such as those disclosed U.S. Pat. Nos. 9,939,533 and 9,002,438 may be used to measure activity at the injection site as a function of time (i.e. time-activity curve or TAC). Referring now to
[0064] Possible scintillation materials 20 include, but are not limited to: Bismuth Germanate (BOO); Gadolinium Oxyorthosilicate (GSO); Cerium-doped Lutetium Oxyorthosilicate (LSO); Cerium-doped Lutetium Yttrium Orthosilicate (LYSO); Thallium-doped Sodium Iodide (NaI(T1)); Plastic Scintillator (Polyvinyltoluene); or Cadmium Zinc Telluride (CZT). In an exemplary embodiment of a measurement sensor 11, multiple scintillation materials 20 adapted to measure different radioisotopes may be used. In another embodiment of a measurement sensor 11, scintillation materials 20 that do not require the use of a light detector 21 may be used. In another embodiment of a measurement sensor, multiple scintillation materials 20, each with their own detection circuitry, may be included to enable a two or three dimensional array of measurements. In some embodiments, the sensor(s) are capable of detecting alpha particles, beta particles, x-rays, gamma rays, and/or other particles/energy indicative of radioactive material.
[0065] Of course, other radiation sensors known in the art may be utilized as desired. For example, radiation sensors capable of detecting alpha particles, beta particles, x-rays, gamma rays or any other kind of radioactive decay particle/energy may be utilized depending on the desired application. Measurement of beta particles, for example, may be advantageous when assessing delivery of a radio-therapeutic to an area of the body as such drugs sometimes release beta particles. It may similarly be advantageous to ensure that certain beta particle (or other particle) emitting drugs or other substances not be reaching a certain part of the body. Thus, sensors could be used to confirm the absence of such substances. All that is typically necessary for the sensors, in some embodiments, is that the sensor be capable of detecting emissions from radioactive material, and further capable of transmitting or otherwise sharing information about those emissions to the system for processing. It may also be desirable, in some embodiments, that the sensors and/or system generally be able to measure an energy level associated with the detected emissions, or filter received energy above or below a certain threshold.
[0066] Utilizing measured data, the rate of reabsorption into the bloodstream may be calculated by observing the activity at the detector as a function of time (i.e. the rate at which radioactive activity leaves the infiltration site). Knowing from the TAC the amount of radioactive material at a time t, and the rate at which it left the infiltration site, an estimate of the initial amount of radioactive material infiltrated may be determined. Knowing this information, the altered injection curve and the reduction of the initial bolus may be plotted, and a function of concentration of radiotracer in the blood as a function of time determined. With that function known, a correction factor for SUV or the like may be applied and the clinician may better diagnose treatment efficacy, etc. Referring now to
[0067] As introduced above, the many constraints on nuclear imaging apparatus (e.g. PET scanners) such as availability, cost, operational resources, etc., make determining the size and/or magnitude of a radioactive source in the body using such apparatuses not always possible. For example, taking a measurement of an infiltration area that may otherwise be outside the field of view and/or otherwise not of interest at the time of the scan is not always feasible. It would also be advantageous to have an understanding of the magnitude and scope of any infiltration from the time of the injection forward, rather than having to wait until the patient is moved to the scanner. The ability to determine the magnitude of an infiltration without using a nuclear imaging scanner may also be desirable because it could eliminate the need to use such a scanner at all where the scope of the infiltration is deemed large enough to render a scan unproductive, thereby saving the patient from additional unnecessary radiation exposure (e.g., from a computerized tomography (CT) scan, or the like).
[0068] It may also be advantageous to measure the area and/or magnitude of radioactive material uptake in an area of interest generally, without having to depend on the availability of more complex and expensive nuclear imaging apparatuses. To determine the efficacy of a treatment to eliminate a tumor, for example, a physician may want to know whether the tumor is shrinking over a period of time (e.g., days, weeks, months, etc.). Requiring a patient to undergo successive nuclear imaging scans and face exposure to the requisite radiation on multiple occasions is, at best, not ideal, and in some cases is prohibitory.
[0069] One way to overcome the difficulties outlined above is, for example, to utilize multiple detectors that may be arranged in a known geometry. Each sensor may measure radioactivity coming from a given source of material, and each sensor may have a known sensitivity thereby enabling it to provide information about intensity measured for each event. Such intensity may depend, for example, on the sensor's distance from the source, material-specific attenuation between source and sensor, as well as intensity of the source itself. As noted above, a determination of each sensor's distance from the source may not be determinable on a sensor by sensor basis because the measured intensity at any given distance depends on an unknown intensity at the source. However, by utilizing data from an array of sensors, and measuring intensity of the same area of different but known relative distances, information regarding both magnitude, location, and/or size of the source may ultimately be determined at each unit of time.
[0070] In some embodiments, and as just one example, a method known as trilateration may be used in combination with the disclosures herein to determine the distance of each sensor from a radiometric center. Trilateration is similar in some respects to triangulation but utilizes distance instead of angles. In some embodiments, each sensor could calculate an estimated distance R to the source based on the measured intensity of each count. The direction of the source, however, would be unknown. Thus, the determined distance dictates only that the source must lie somewhere on a sphere of radius R centered about the sensor. Having such a sphere for multiple sensors (e.g., four) positioned in 3-D space, however, a point where the four spheres intersect could identify the radiometric center of the source material, and allow for the system to know the distance between a radiometric center of the source material and the sensor.
[0071] Referring now to
[0072] Various different sensors capable of measuring counts in the presence of radioactive material are available and known in the art. These include, but are not limited to: the sensors disclosed hereinabove with reference to
[0073] As noted above, the relative geometry of the sensor array must be known, but that geometry is otherwise generally unrestrained, both in space and time. In some embodiments, so long as the relative geometry of the sensors is known at each time t, the relative distances of each sensor to the radiometric center be determined. Note, however, that in some embodiments it may be necessary that the sensors be disposed in a three-dimensional array, rather than all residing, for example, on a similar two-dimensional plane, or in a one-dimensional line.
[0074] Referring now to
[0075] In some embodiments, the various sensors discussed herein that may be arranged in an array to determine a radiometric center of a radiation source that may be the same sensor(s) that measure the time-activity curve (TAC) discussed above. Accordingly, as disclosed herein, the sensors may be utilized to detect an infiltration, measure the time-activity curve at the injection/infiltration site, and even measure the magnitude of the infiltration so as to yield information about the SUV, for example, of an area of interest (e.g. tumor) ultimately measured by a nuclear imaging device (e.g., PET scan) and any correction factor that may need be applied in view of, for example, an imperfect injection of radiotracer.
[0076] In certain other embodiments of the present disclosure, the system may utilize arrays of sensors in combination with other estimation techniques to, for example, quantify and/or measure the magnitude and/or location/size of a radioactive area of interest. In some embodiments, and referring now to exemplary
[0077] The array of sensors 1110 may include any number of sensors, including in some embodiments as few as one or two, or as many as four, eight, ten, twenty, thirty, fifty, one-hundred, or more or anywhere in between. Further, each of the plurality of sensors 1110 that make up the array may be identical sensors to one another, or one or more may have unique characteristics relative to one or more other of the sensors 1110. Such distinguishing characteristics may include, but are not limited to, different shielding configurations, different energy threshold settings for detection, different size/shape for given locations or applications, etc. Other varying characteristics may also be utilized, some of which are discussed in greater detail elsewhere in this disclosure.
[0078] In some embodiments, each sensor 1110 may detect particles/energy emitted from the radioactive area of interest 1103. In some embodiments, the sensors 1110 may detect the emitted particles as discussed hereinabove (e.g., through use of scintillation material that emits light when impacted with radioactive particles (e.g., alpha particles, beta particles, or the like) in the sensor and circuitry capable of counting the number of hits per unit time). As noted above, however, other sensor configurations and detection methods may be used.
[0079] In general, the array of sensors 1110 may be arranged in any desired geometry relative to each other and relative to the area of interest 1101. In some embodiments, it may be advantageous to utilize a known geometry of sensors, and it may be further advantageous to arrange the sensors 1110 such that the location of each sensor 1110 may be known relative to each of the other sensors 1110 in the array.
[0080] Using techniques known to those having skill in the art, it is possible to estimate the radioactive activity expected at a given location (e.g., at the location of a specific sensor 1110) given certain information, including for example a known amount of radioactive material centered about a known point in space. For example, if the radiometric center, and amount and type of radioactive material is known, and information about the density and composition of the material through which the emitted particles will pass to reach the sensor 1110 (e.g., water, tissue, bone, etc.), one may determine a likelihood that a particle emitted from the radiation source would be detected at a given point in space. Using these techniques, a set of expected measurements can be generated for radioactive sources of various magnitudes, locations, and volumes.
[0081] Accordingly, by inversing such calculations, measurements of activity taken at various points in space relative to a source of radioactive material may be used to estimate characteristics about the radioactive material source itself, for example, magnitude, location, volume, etc. In one example, activity at various locations about a radioactive source may be measured as a function of time. Then, knowing the likelihood of measuring the activity actually measured relative to radioactive sources of various magnitudes and locations, a least squares regression analysis may be used to estimate the magnitude, location, and/or volume of the actual radioactive material source. Using such techniques, and assuming a distribution, for example Gaussian, of radioactive material, an accurate determination of the amount of radioactive material present can be determined (i.e., the magnitude), and the radiometric center of the radioactive material (i.e., location), and/or distribution of radioactive material (i.e., size of the source of radioactive material) may be determined.
[0082] According to one exemplary method of using the system disclosed herein, and referring again to
[0083] Having measured the activity of direct hits per unit time at each known location, the least squares regression analysis can be applied to find the magnitude (A), mean location () and standard deviation () of the radioactive source which minimizes the error between actual counts (c.sub.n) and estimated counts (.sub.n) associated with the various possibilities of radioactive sources. In some embodiments, the system or method may assume a Gaussian distribution of the radioactive material of interest, but other distributions are possible. Knowing such information, it may be possible to diagnose certain conditions, determine a dose of radiation to tissue in the body proximate the radioactive source, analyze whether a desired dosage of therapeutic radiopharmaceutical has been delivered to an area of interest (or is not present in an area of interest or below some acceptable threshold), and by capturing such exact measurements, it may be possible to compare results for a single patient over multiple visits to track efficacy of treatments, etc.
[0084] One drawback to this technique may be that the standard deviation of the distribution is sometimes difficult to determine accurately. For example, the counts or hits measured by an array made of sensors 1110 may be the same for a collection of radioactive material distributed over a first volume as it would for a collection of the same amount of radioactive material distributed over a second volume. Accordingly, while the magnitude of the source (i.e., how much radioactive material is present) and radiometric center of the source (i.e., the location about which the radioactive source is centered) may be determined, the volume of space that the source occupies may be more difficult to estimate according to some techniques. While magnitude and location can provide significantly advantageous information in some circumstances (e.g., determining the size and location of an infiltration and using that information to aid in interpretation of medical imaging, for example), it is not always sufficient to determine, for example, the radioactive dose to surrounding tissue, as the distribution of the radioactive material (i.e. the standard deviation discussed above) in the tissue would be needed.
[0085] Accordingly, it would be advantageous to modify and/or supplement the techniques described hereinabove to determine not only the magnitude and location of a radioactive area of interest (e.g., 1103), but also gain an understanding of the volume/distribution of the material.
[0086] According to additional embodiments of the present disclosure, sensor arrays not unlike those discussed hereinabove may be used in combination with other methods to obtain even more robust estimates of the magnitude, location, and/or volume of a radioactive area of interest. Referring now to
[0087] Similar to the sensor array discussed hereinabove, each of the sensors 1210 may be positioned proximate a known location relative to the plurality of other sensors 1210. The sensors 1210 may be arranged at random known locations about the volume of interest 1201, or in preferred embodiments, may be positioned in mathematically advantageous geometries about the volume of interest 1201, including for example, in triangular, cubic, hemispherical or spherical orientations about the volume of interest 1201, among others. In some embodiments, the arrangements may be symmetrical. In the exemplary embodiment illustrated in
[0088] In some embodiments, a system for estimating the magnitude, location, and volume of a radioactive area within a volume of interest, such as for example the system 1200 illustrated in
[0089] For example, and referring again to
[0090] Particles released from radioactive material travel in random directions from their source, and therefore there is only a chance that any particular particle (e.g., particle 1320) will travel in the direction of a given sensor (e.g., sensor 1310). Further, the greater the distance between the source of the particle 1320 and the sensor 1310, the more likely it is that the particle 1320 will collide with some intervening material (e.g., water molecule, bone, etc.) and scatter to a different trajectory. When scattered, the particles lose energy, and therefore it is possible to calibrate the sensors to disregard scattered particles that may be received at a sensor, if desired, as counting scattered particles may introduce error.
[0091] Accordingly, referring again to
[0092] The same is true for a three-dimensional configuration, such as for example the configuration illustrated in
[0093] Knowing these probabilities, the system 1200 may be used to take actual measurements of hits per unit time observed at each sensor 1210 and estimate, among other things, the magnitude, location, and/or volume of a radioactive source. In some embodiments, because the radioactive material releases particles in all directions, each sensor 1210 should register some number of hits if a sufficient amount of radioactive material is present within volume of interest 1201. Each hit at each sensor 1210 corresponds to a set of probabilities across the voxels 1205 in the volume of interest 1201 corresponding to the likelihood that the particle (e.g., 1220) intercepting a particular sensor 1210 originated in each voxel 1205. In some embodiments, the system may analyze the sets of probabilities for each hit at each sensor 1210 and iterate over time to determine the most likely distribution of radioactive material 1203 within the volume of interest 1201 that would generate the hits observed. The system may also iterate over various energy levels, providing additional detail.
[0094] Generally speaking, increasing the number of available sensors (e.g., 1210) positioned about the radioactive material source (e.g., 1203) may increase the accuracy with which the system 1200 can estimate the magnitude, location, and/or volume of the source. Similarly, increasing the number of voxels used in the calculations (i.e., more voxels comprising smaller and smaller volumes each) may increase the system's accuracy. However, as the number of sensors and/or voxels increases, the number of required calculations and processing requirements of the system generally increases significantly. It may therefore be advantageous, in some embodiments, to take advantage of certain sensor positioning arrangements that may simplify calculations or aid in the iterative convergence of the calculations, including for example using symmetrical sensor configurations, among other things. Such configurations may also shorten the time and/or reduce the number of calculations required to achieve acceptable iterative convergence. Various distributions of voxel size may also be utilized, such that smaller voxels are utilized closer to and within the radioactive source material 1203 and larger voxels are utilized elsewhere, for example.
[0095] In some embodiments, in may also be advantageous to include two or more sensors proximate each of the fixed points about a volume of interest. An exemplary configuration illustrating an exemplary dual-sensor approach is illustrated in
[0096] In some embodiments, it may be advantageous to detect particles from plurality of radioactive sources. For example, by introducing two or more radiopharmaceuticals with distinguishable radioactive characteristics (e.g., different energy levels, different uptake rates, etc.), additional information may be detected. Sensors in such systems may be tuned to detect particles of one or more different energy levels, thereby providing additional information. For example, the amount or rate of uptake of one drug associated with a first radiopharmaceutical relative to the amount rate of uptake of a second drug associated with a second radiopharmaceutical may provide useful information to a clinician.
[0097] Referring now to
[0098] In some embodiments, the sensors 1510 of cuff 1550 may also be arranged to provide for substantially stacked sensors at various locations on cuff 1550. For example, and similar to the exemplary cubic configuration discussed above with reference to
[0099] In the event of an infiltration, for example, the system 1500 could be used according to some or all of the methods taught hereinabove to estimate the magnitude, location, and/or volume of the infiltrated radioactive material in the patient. Advantageously, the system may also be utilized, in some embodiments, to provide estimates of the magnitude, location, and volume over time, thereby providing critical information to healthcare providers regarding, among many other things, the rate at which radioactive material is being introduced into the bloodstream and therefore affecting, for example, nuclear imaging, and to quantify the patient's tissue exposure to the infiltrated radiation at or around the injection site, to name just a few.
[0100] In certain other embodiments, similar arrangements of sensors may be utilized in other configurations for use in other areas of the body. For example, referring now to
[0101] Referring now to
[0102] The helmet 1750 may also include a transition layer similar to layer 1555 in
[0103] In each of these various embodiments, the relative distance between sensors may initially be unknown given the need to modify the cuff 1550, 1650 or helmet 1750 to fit the various sizes and shapes of patients presented. To calibrate the various systems 1500, 1600, and/or 1700 (and others) before use, the systems and methods taught herein may be modified to introduce known radioactive elements at known locations. For example, relatively small doses of cesium, for example, may be introduced at a known location, from which the relative locations of each sensor may be determined by the system.
[0104] In another example, known amounts of cesium (or some other radioactive material) may be introduced to determine the specific density of a patient's body through which the particles released from a radiopharmaceutical may travel.
[0105] By determining reliable estimates of one or more of the magnitude, location, and/or volume of a radioactive source material in the body, it may be possible to, among many other things, evaluate treatment efficacy, make clinical decisions or diagnoses, identify or eliminate medical conditions, compare different areas of the body (e.g., different hemispheres of the bran) and make clinical decisions and/or diagnoses based on such measurements and/or by comparing such measurements to past measurements of the patient and/or measurements of the general population, among many other things. The systems and methods taught herein are expected not only to provide such estimates, but to use such estimates to aid clinicians in their diagnosis and treatment, and even suggest or determine appropriate clinical decisions and/or diagnosis.
Attenuation Estimations and Corrections
[0106] In some embodiments, the systems and methods taught hereinabove may further include mechanisms for measuring and/or estimating a position of different materials within a measurement region of interest so as, for example, to better understand the various densities and resulting attenuation through the system. In doing so, the system and method can more accurately account for different materials having relatively different densities in the system, thereby better estimating a particle's energy loss as it travels along a path from its origin to a sensor.
[0107] More particularly, and referring again to the exemplary system depicted in
[0108] In some circumstances, however, it may be more difficult, impracticable, or otherwise less desirable to rely on having a deformable transition layer 1555 to aid in maintaining a relatively uniform density between the radiation source 1503 and the sensor 1510. In many cases, for example, one or more air gaps may be unavoidable, and/or a system configuration may be desired where air gaps of known or unknown size may be necessary to facilitate, for example, patient comfort, system design, cost considerations, etc.
[0109] Referring now to
[0110] Referring again to the exemplary system presented in
[0111] One current (and often cost prohibitive) method for accounting for such varying material densities and attenuation along a particle's path is to use computed tomography (CT). CT consists of multiple x-ray images taken from various angles to build a 3D image of the patient's anatomy in terms of density. Then, the CT image can be used to correct for the photon energy lost due to absorption between any point and any detector. But for the system disclosed herein, size and cost are two of several important design requirements. Incorporation of CT imaging would be disadvantageous to both. It is therefore a further object of the present invention to provide systems and methods for better estimating various densities throughout the area within, for example, cuff system 1800, so as to better account for a particle's attenuation as it travels from a point of origin (e.g. Point 1) to a measurement sensor 1810.
[0112] Referring now to
[0113] In some embodiments, rangefinders 1895 may include one or more devices which measure a straight-line distance between itself and an object in front of it. Such rangefinders 1895 may utilize different known technologies, including for example, ultrasonic and optical designs, but are not so limited and may include any method of determining or calculating a distance relative to the rangefinder 1895.
[0114] In one example, ultrasonic detectors, for example, may be based on the principle of time-of-flight and can be similar to SONAR. In some embodiments, a pulse of ultrasonic energy may be emitted from the device. Then, the time required for an echo of that pulse to be received back at the device may be measured. The measured time can relate to a distance based on the known speed of ultrasonic transmission through the intervening medium (e.g., air 1890). Ultrasonic time-of-flight rangefinder devices may have several advantages, including among others relatively low power consumption, relatively high distance range, little impact from target color or transparency, and relatively low cost. Disadvantages of ultrasound time-of-flight may include relatively low measurement resolution, relatively low measurement rate, relatively large physical size, susceptibility to ambient ultrasonic noise and echoes, among others.
[0115] In another example, optical range-finding devices may operate in one of two exemplary manners, among others. In one example, triangulation may be used. To use triangulation, an optical emitter and receiver may be required. The emitter may generate a beam of light, for example in the infrared spectrum. The receiver may then record the angle at which the emitted light is reflected. The angle of reflection may be related directly to a distance. Advantages of optical triangulation may include relatively small size, relatively high measurement rate, commercial availability of relatively short- and long-range versions, and relatively good spatial resolution to name a few.
[0116] In another example, optical time-of-flight may be used, which is similar in many respects to ultrasonic time-of-flight, but instead uses light. The light used may be in the infrared spectrum or any other spectrum. Optical time-of-flight systems may utilize so-called light detection and ranging systems (e.g. LIDAR) and/or vertical cavity surface emitting lasers (VCSEL), to name just a few. Advantages of such systems may include, among others, high measurement rates, long range, high accuracy, and good spatial resolution.
[0117] In one exemplary embodiment, a VCSEL optical rangefinder may be utilized. As will be known by a person having ordinary skill in the art, rangefinders based on VCSEL modules may be available with a measurement range of near zero to approximately 1 meter with accuracy of approximately 2-4 mm. Their measurement rate may typically be about 10 samples/second. They may be designed to be positioned behind a protective glass surface, and as such may include features to ignore reflected light from that surface.
[0118] Referring now to
[0119] In one example, the system may use a least-squares method to fit a geometrical shape (e.g. circle or ellipse). In other embodiments, other estimation techniques known in the art may be utilized to generally determine which portions of the interior area 1801 are filled by the patient's arm 1860 and which portions of interior area 1801 include, for example, only air 1890. Accordingly, the system 1800 would be able to determine the location of the arm 1860 relative to each of the one or more radiation sensors 1810 at any given point in time, thereby enabling the system to account for the relative differences in attenuation of a particle emitted from a radioactive area of interest 1803 as it travels to a sensor 1810. This additional information may be used to improve upon the estimation techniques disclosed hereinabove.
[0120] As noted above, the exemplary systems and methods disclosed hereinabove are not limited to a patient's arm (e.g., arm 1860), but any portion of the body or any area or region surrounding any radioactive area of interest. For example, the exemplary embodiments disclosed in, for example,
[0121] In certain additional embodiments, systems and methods disclosed herein may further estimate the size and/or location of bone proximate an area of interest within the body and account for its relatively dense characteristics relative to tissue or air. Referring again to
[0122] Further, in some embodiments, the various arrangements of one or more rangefinders 1895 may be arranged not only in the 2-D configurations depicted in, for example,
[0123] Additionally, in certain other embodiments, various other methods for estimating the size and/or shape of the tissue within a measurement area (e.g., the size and shape of arm 1860 within cuff 1800) may be utilized. For example, in some embodiments, one or more rangefinders 1895 may be utilized that are capable of scanning across an area of interest, thereby enabling measurements to be taken across various angles known angles within the system to capture more information and detail for determining the position and/or size of tissue/bone, etc. within the measurement region.
[0124] Alternatively, a system of lasers and/or cameras may be utilized to determine the size and/or location of tissue in the area of interest (e.g. arm 1860 in cuff 1800). Referring now to
[0125] Referring now to
[0126] As will be appreciated by those having ordinary skill in the art, substantially symmetrical (e.g. cylindrical) systems may not always be most advantageous for use with the varying shapes and sizes of the human anatomy or any other radioactive area of interest. For example, while not limited to such configurations, the depicted cylindrical configurations depicted in, for example,
[0127] Referring now to
[0128] Other such arrangements are also contemplated by the present disclosure. For example, and referring now to
[0129] In certain other embodiments, plates 2301 and 2302 may be curved as depicted, for example, in
[0130] In certain other embodiments, a combination of the arrangements disclosed in
[0131] The present disclosure is non-limiting and may further include any other manner or means for determining the position of an object (e.g., a patient's arm, torso, or head) within a measurement area. Further examples may include any mechanisms for tracking the position of multiple targets in 3-D space, including optical tracking systems that use, for example, cameras and/or one or more light emitters; magnetic tracking systems that may utilize one or more magnetic detectors; radio-frequency (RF) tracking systems (e.g., radar); acoustic tracking systems; image recognition systems (e.g., 3d pose estimation and/or articulated body pose estimation); 3D scanning systems; and the like.
[0132] In certain other embodiments, a contour gauge system such as the exemplary systems 2500 disclosed in
[0133] In certain other embodiments, mechanisms for determining the location of, for example, an arm 2560 may be utilized that account for clothing or other objects that may otherwise interfere with the detection systems described hereinabove. In one example, rods such as those depicted in
[0134] Other methods for determining a relationship between a detector rod and arm surface may also be utilized, including for example electrical skin conductivity, capacitance, inductance, ambient light, temperature, electrical signals from the body, heart beat detection, and others.
[0135] The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the claims of the application rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.